SCHEMBL30773453

SCHEMBL30773453

COc1cc(C)c([N+](=O)[O-])cc1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.54
▸ TDP1 Q9NUW8 3/20 0.53
▸ ALDH1A1 P00352 4/20 0.49
▸ CYP3A4 P08684 4/20 0.49
▸ TSHR P16473 3/20 0.49
▸ RECQL P46063 1/20 0.49
▸ MAPT P10636 4/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ PRKDC P78527 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ GAA P10253 1/20 0.43
▸ MEN1 O00255 1/20 0.41
▸ G6PD P11413 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ APOBEC3G Q9HC16 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6677617 1.00 HTT (0.54) HTTTDP1ALDH1A1CYP3A4TSHR
SCHEMBL5479455 0.93 HTT (0.54) HTTTDP1ALDH1A1CYP3A4TSHR
SCHEMBL10020888 0.87 HTT (0.59) HTTTDP1ALDH1A1CYP3A4TSHR
SCHEMBL3647381 0.86 HTT (0.50) HTTTDP1ALDH1A1CYP3A4TSHR
SCHEMBL6376231 0.85 HTT (0.58) HTTTDP1ALDH1A1CYP3A4TSHR
SCHEMBL8009996 0.85 HTT (0.58) HTTTDP1ALDH1A1CYP3A4TSHR
SCHEMBL3294994 0.85 ALDH1A1 (0.59) HTTTDP1ALDH1A1CYP3A4TSHR
Hydrochloric Acid SCHEMBL2206406 0.84 GAA (0.49) HTTTDP1ALDH1A1CYP3A4TSHR
SCHEMBL9073829 0.84 HTT (0.56) HTTTDP1ALDH1A1CYP3A4TSHR
SCHEMBL31077653 0.83 ALDH1A1 (0.50) HTTTDP1ALDH1A1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024064091-A1 NOVEL PYRIMIDINE COMPOUND AS KINASE INHIBITORS WITH BIOLOGICAL ACTIVITIES ON EGFR MUTANTS Advenchen Pharmaceuticals, LLC (US) 2024-03-28 — — WO disclosed
Send feedback